B
Benjamin L. Schulz
Researcher at University of Queensland
Publications - 360
Citations - 25967
Benjamin L. Schulz is an academic researcher from University of Queensland. The author has contributed to research in topics: Galaxy & Glycosylation. The author has an hindex of 84, co-authored 348 publications receiving 24069 citations. Previous affiliations of Benjamin L. Schulz include ETH Zurich & University of Hawaii.
Papers
More filters
Journal ArticleDOI
The intrinsic and regulated proteomes of barley seeds in response to fungal infection
Edward D. Kerr,Toan K. Phung,Christopher H. Caboche,Glen P. Fox,G.J. Platz,Benjamin L. Schulz +5 more
TL;DR: Fungal burden in the leaves and stems of barley resulted in changes to the seed proteome, however, these changes were minimal and showed substantial variation among barley samples infected with different pathogens.
Journal ArticleDOI
Proteomic Investigation of the Binding Agent between Liver Glycogen β Particles.
Xinle Tan,Mitchell A. Sullivan,Sharif S. Nada,Bin Deng,Benjamin L. Schulz,Robert G. Gilbert,Robert G. Gilbert +6 more
TL;DR: Evidence is provided using qualitative and quantitative proteomics and size-exclusion chromatography from healthy rat, mouse, and human liver glycogen that glycogenin is the binding agent linking β particles together into α particles.
Journal ArticleDOI
CONFECT: Conformations from an Expert Collection of Torsion Patterns
Christin Schärfer,Tanja Schulz-Gasch,Jérôme Hert,Lennart Heinzerling,Benjamin L. Schulz,Therese Inhester,Martin Stahl,Matthias Rarey +7 more
TL;DR: A new conformation generator called CONFECT is presented that builds on the previously published library of torsion patterns and allows the efficient generation of high‐quality conformation ensembles that effectively cover conformational space.
Identification of salivary N-glycoproteins and measurement of glycosylation site occupancy by boronate glycoprotein enrichment and liquid chromatography/electrospray ionization tandem mass spectrometry
TL;DR: A sample preparation and mass spectrometry detection strategy for rapid and efficient measurement of site-specific glycosylation occupancy on diverse salivary glycoproteins suitable for biomarker discovery and detection of changes in glycosYLation occupancy in human disease is developed.
Journal ArticleDOI
Recombinant truncated AniA of pathogenic Neisseria elicits a non-native immune response and functional blocking antibodies.
Lucy K. Shewell,Shan C. Ku,Benjamin L. Schulz,Freda E.-C. Jen,Tsitsi D. Mubaiwa,Margaret R. Ketterer,Michael A. Apicella,Michael P. Jennings +7 more
TL;DR: It is proposed that recombinant modified AniA has potential as a vaccine antigen for N. gonorrhoeae because of its glycosylation state and the strong humoral immune response to the basal monosaccharide.